Henry Schein Names Bridget A. Ross To Lead Global Medical Group

MELVILLE, N.Y., Feb. 9, 2017

Ms. Ross, 52, will join Henry Schein from Johnson & Johnson, where she spent more than 28 years in sales, marketing and general management roles. At Henry Schein, she will serve as a member of the company's Executive Management Committee (EMC) and report to Karen Prange, Executive Vice President and Chief Executive Officer, Global Animal Health, Medical, and Dental Surgical Group. Ms. Ross's appointment is effective February 14, 2017.

In her new role, Ms. Ross will be responsible for overall leadership of the Global Medical Group, including strategic direction, management, and business performance. In partnership with her team, she will be responsible for the group's sales, marketing, operations, business development, and technology solutions.

"This is a period of transformational change and consolidation in the global medical industry, and Henry Schein is committed to helping lead customers through this transformation for the benefit of their patients," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, Henry Schein, Inc. "Bridget has the talent, energy, and experience necessary to successfully manage large organizations during periods of great change. As market, technological, and demographic forces converge to create unique business opportunities for Henry Schein, we are delighted that Bridget will join us to make the most of these opportunities."

Immediately prior to joining Henry Schein, Ms. Ross was Vice President, Commercial Operations, North America, for J&J's Medical Devices Group, a $25 billion business. In this role, she led a commercial operations integration in North America, bringing together three franchises and several National Account Management groups while supporting more than 5,000 commercial employees across multiple businesses. Prior to that assignment, Ms. Ross held roles including Global President of Acclarent Inc. and Global President of Ethicon's Women's Health & Urology, both J&J Medical Device companies. 

"Bridget joins Henry Schein with a significant track record in leading and growing global businesses," said Ms. Prange. "Bridget drove business results and led teams in multiple therapeutic areas, where she consistently demonstrated a passion for people development and innovation. We look forward to Bridget bringing that same passion to Henry Schein as we deepen our investment in the medical industry during this time of tremendous opportunity."